Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 20, Issue 6, 2013, Pages 2088-2095

  Wong, Ruey Hong ^a,b   Huang, Chun Huang ^a   Yeh, Chao Bin ^a,b   Lee, Hong Shen ^a,b   Chien, Ming Hsien ^c,d   Yang, Shun Fa ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOTHIONEIN I;

ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; MALE; METALLOTHIONEIN; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84878229475     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2456-6     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Department of Health, Taiwan. Republic of China. Health statistics: II. Vital statistics. Taipei: Department of Health, 2009.
3. Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene. 2010;29:2309-24.
4. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674-87.
5. Wang LY, You SL, Lu SN, et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control. 2003;14:241-50.
6. Altamirano J, Bataller R. Cigarette smoking and chronic liver diseases. Gut. 2010;59:1159-62.
7. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci. 2009;1155:206-21.
8. You HJ, Oh DH, Choi CY, et al. Protective effect of metallothionein-III on DNA damage in response to reactive oxygen species. Biochim Biophys Acta. 2002;1573:33-8.
9. Namdarghanbari M, Wobig W, Krezoski S, Tabatabai NM, Petering DH. Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem. 2011;16:1087-101.
10. Maret W, Vallee BL. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA. 1998;95:3478-82.
11. Endo T, Yoshikawa M, Ebara M, et al. Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents. J Gastroenterol. 2004;39:1196-201.
12. Tao X, Zheng JM, Xu AM, Chen XF, Zhang SH. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol Res. 2007;37:820-7.
13. Pedersen MØ, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem. 2009;44:29-64.
14. Le Beau MM, Diaz MO, Karin M, Rowley JD. Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia. Nature. 1985;313:709-11.
15. Kelly EJ, Sandgren EP, Brinster RL, Palmiter RD. A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes. Proc Natl Acad Sci USA. 1997;94:10045-50.
16. Yang L, Li H, Yu T, et al. Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab. 2008;294:E987-92.
17. Zavras AI, Yoon AJ, Chen MK, Lin CW, Yang SF. Metallothionein-1 genotypes in the risk of oral squamous cell carcinoma. Ann Surg Oncol. 2011;18:1478-83.
18. Drasch GA, Kretschmer E, Neidlinger P, Summer KH. Metallothionein in human liver and kidney: relationship to age, sex, diseases and tobacco and alcohol use. J Trace Elem Electrolytes Health Dis. 1988;2:233-7.
19. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52(Suppl. 3):iii1-iii8.
20. Weng CJ, Hsieh YH, Tsai CM, et al. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010;17:1808-15.
21. Sobin LH, Wittekind C; International Union Against Cancer. TNM classification of malignant tumors. 6th ed. New York: Wiley Liss, 2002.
22. Tsai JF, Jeng JE, Ho MS, et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer. 1997;76:968-74.
23. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-9.
24. Glad CA, Johannsson G, Carlsson LM, Svensson PA. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP. Growth Horm IGF Res. 2010;20:270-3.
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-5.
26. Cardoso SV, Silveira-Júnior JB, De Carvalho Machado V, De-Paula AM, Loyola AM, De Aguiar MC. Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma. Anticancer Res. 2009;29:1189-93.
27. Datta J, Majumder S, Kutay H, et al. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. Cancer Res. 2007;67:2736-46.
28. Majumder S, Roy S, Kaffenberger T, et al. Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes. Cancer Res. 2010;70:10265-76.
29. Richards RI, Heguy A, Karin M. Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. Cell. 1984;37:263-72.
30. Vandeghinste N, Proost P, De Ley M. Metallothionein isoform gene expression in zinc-treated human peripheral blood lymphocytes. Cell Mol Biol. 2000;46:419-33.
31. Giacconi R, Kanoni S, Mecocci P, et al. Association of MT-1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort. J Nutr Biochem. 2010;21:1008-14.
32. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology. 1991;13:398-406.
33. Nishikawa A, Mori Y, Lee IS, Tanaka T, Hirose M. Cigarette smoking, metabolic activation and carcinogenesis. Curr Drug Metab. 2004;5:363-73.
34. Jeng JE, Tsai JF, Chuang LY, et al. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 2007;9:987-92.